Short answer
SANUWAVE Health, Inc. (SNWV) filed an 8-K current report with the SEC on November 10, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 financial results announced for quarter ended September 30, 2026.
SANUWAVE Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2026 financial results announced for quarter ended September 30, 2026
- Business update conference call scheduled November 11, 2026 at 8:30 a.m. EST
- Investors should review the accompanying press release for reported financial figures and management commentary
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $8.6M, down 24% from $11.3M, reflecting sharply weaker Ultramist system demand
- Ultramist systems sold fell to 40 from 155, while applicator revenue increased 2% to $6.9M, highlighting recurring-revenue resilience
- Operating loss $1.1M versus $0.9M income, with Adjusted EBITDA declining to $0.7M from $3.2M
- Net loss $1.4M versus $9.7M income, amplified by nonrecurring prior-year gains of $6.1M and $5.0M
- Cash $6.6M after approximately $2.3M in sales-tax payments, increasing liquidity risk amid $5.4M remaining term-loan debt repayments during nine months
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SANUWAVE Health, Inc. 8-K filings
Get the next SNWV 8-K as it lands
Follow SNWV for push alerts, or ask the research agent what this filing means.